Kaplan–Meier survival analyses revealed an association between high expression levels of AKAP12 and adverse OS (p = 8.7e-08 and p = 1.2e-09, respectively), and PPS (p = 0.015 and p = 4.3e-08, respectively) for OV and gastric cancer (GC), poor PFS for OV (p = 2.4e-06), and poor first progression (FP) for GC (p = 4.6e-08) (Supplementary Figure S3). Here, AKAP12 is linked to gastric cancer.